A revolutionary new study in mice could pave the way for curing type 1 diabetes by creating a blended immune system that ...
Histopathological and immunohistochemical features of the solid pseudopapillary neoplasm. ( A ) Basophilic calcifications within hyalinized fibrous areas (arrows) (H&E, ×400). ( B ) Tumor with focal ...
Pancreatic cancer continues to be a devastating disease, with an overall 5-year survival rate of around 13%. Accounting for about 3% of all cancers, it is the third leading cause of cancer death in ...
Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the pancreas lure nerve fibers, which then release signals that accelerate early ...
New AI diagnostic, Vitara Pancreas ChemoPredict, can select optimal first-line treatment for advanced pancreatic cancer patients. PALO ALTO, Calif.--(BUSINESS WIRE)--Valar Labs, a leader in ...
New AI diagnostic, Vitara Pancreas ChemoPredict, can select optimal first-line treatment for advanced pancreatic cancer patients. Valar Labs, a leader in computational histology and precision oncology ...
Medicaid Expansion and Stage at Diagnosis, Timely Initiation and Receipt of Guideline-Concordant Treatment, and Survival Among People With Non–Small Cell Lung Cancer The CHAI platform extracted ...
Valar Labs, a leader in computational histology and precision oncology, today announced the publication of a major study in the Journal of Clinical Oncology (JCO), a premier, peer-reviewed medical ...
Abstract: Background: Frozen section (FS) tissue assessment is essential for guiding intraoperative surgical decision-making in oncology, particularly in procedures such as pancreatic ductal ...
Targeted MAPK pathway inhibition with atebimetinib contrasts with nonselective cytotoxic chemotherapy and is paired with a dose-schedule modification intended to ...
Current drugs for pancreatic cancer lose effectiveness within months because the tumor becomes resistant. Now, a group from Spain's National Cancer Research Centre (CNIO) has been able to avoid the ...
Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...